Latest Prospectus Stories

ORLANDO, Fla., April 18, 2013 /PRNewswire/ -- SeaWorld Entertainment, Inc. ("SeaWorld Entertainment"), a leading theme park and entertainment company, today announced the pricing of an initial public offering of 26,000,000 shares of its common stock at $27.00 per share.  (Photo: http://photos.prnewswire.com/prnh/20130418/FL97697-a )(Photo: http://photos.prnewswire.com/prnh/20130418/FL97697-b )(Logo: http://photos.prnewswire.com/prnh/20130418/FL97697LOGO-c ) SeaWorld Entertainment is...

BETHESDA, Md., April 18, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today that on April 17, 2013, it entered into an agreement with one healthcare-dedicated institutional investor for a registered direct placement of $10 million of common stock at the closing market price of $3.90 per share. (Logo:...

ANNAPOLIS, Md., April 17, 2013 /PRNewswire/ -- Hannon Armstrong Sustainable Infrastructure Capital, Inc., announced today the pricing of its initial public offering of 13,333,333 shares of common stock at a price of $12.50 per share. The common stock is expected to begin trading on the New York Stock Exchange on April 18, 2013 under the ticker symbol "HASI." (Logo: http://photos.prnewswire.com/prnh/20130417/PH97000LOGO ) Hannon Armstrong Sustainable Infrastructure Capital, Inc....

ALLENTOWN, Pa., April 17, 2013 /PRNewswire/ -- Taminco Corporation (the "Company") announced today the pricing of its initial public offering of 15,789,474 shares of common stock at a price to the public of $15.00 per share. The Company has granted the underwriters an option to purchase up to 2,368,421 additional shares at the initial public offering price less underwriting discounts and commissions. No selling stockholders are participating in the offering, including in respect of...

PHILADELPHIA, April 17, 2013 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that it has priced an underwritten public offering of 10,300,000 common units representing limited partner interests at an offering price of $34.00 per unit. The underwriters have been granted a 30-day option to purchase up to an additional 1,545,000 common units. The Partnership intends to use the net proceeds from this offering to...

BOULDER, Colo., April 17, 2013 /PRNewswire/ -- Rally® (NYSE: RALY), a leading provider of cloud-based solutions for managing Agile software development, today announced the closing of its previously announced initial public offering of 6,900,000 shares of its common stock at a price to the public of $14.00 per share, which included 900,000 shares of common stock issued upon the exercise in full of the underwriters' option to purchase additional shares. The shares began trading on...

ELMSFORD, N.Y., April 16, 2013 /PRNewswire/ -- BioScrip, Inc. (NASDAQ: BIOS) (the "Company" or "BioScrip") today announced it has commenced an underwritten public offering of its common stock. Both the Company and certain selling stockholders will offer shares of the Company's common stock as part of the public offering. BioScrip will not receive any proceeds from the sale of shares of common stock by the selling stockholders. (Logo:...

PHILADELPHIA, April 16, 2013 /PRNewswire/ -- Atlas Pipeline Partners, L.P. (NYSE: APL) ("APL", "Atlas Pipeline", or the "Partnership") announced today that it has commenced an underwritten public offering of 10,300,000 common units representing limited partner interests. Citigroup, BofA Merrill Lynch, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, and Wells Fargo Securities are acting as joint book-running managers for this offering. The underwriters have been granted a 30-day...

PRINCETON, N.J., April 16, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, today announced the closing of its previously-announced initial public offering of 8,000,000 shares of its common stock at $8.00 per share. Omthera's common stock is listed on the NASDAQ Global Market under the trading symbol "OMTH"....

TEL AVIV, Israel, April 16, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR) announced the closing of an underwritten public offering of 12.5 million shares of its common stock at a price to the public of $2.00 per share. The Company received net proceeds of approximately $22.6 million, after deducting underwriting discounts and commissions and other offering-related costs. InspireMD granted the underwriters a 30-day option to purchase up to...